4baseCare, a precision oncology company, inaugurated its new genomics laboratory in Mahadevapura, Bengaluru, as a part of its consistent efforts to advance access to precision oncology in India. The highlight of the launch event was the unveiling of Global Cancer Diversity Atlas (GCDA) aimed at addressing the genomics data gap that exists in cancer care.
The launch event was presided over by Mr. N. R. Narayana Murthy, Chairman, Infosys, who also unveiled the Global Cancer Diversity Atlas. In attendance were Ganapathy Subramaniam, Founding Managing Partner at Yali Capital, Rajan Anandan, Managing Director , Peak XV Partners, and founders of 4baseCare, Hitesh Goswami and Kshitij Rishi.
 |
 |
4baseCare’s new genomics lab in Bengaluru will offer advanced genomic testing solutions including comprehensive gene panels, whole exome sequencing, and transcriptome analysis. These tools will enable oncologists to delve deeper into the genetic makeup of tumors, offering personalized and more effective cancer treatment options.
The Global Cancer Diversity Atlas (GCDA) is a pioneering initiative by 4baseCare designed to address a critical gap in global cancer research: the lack of genomic data from diverse populations. While most cancer genomic datasets are dominated by Western populations, GCDA is built on real-world data from India and the Global South, including South Asia, Southeast Asia, the Middle East, Central Europe, and Latin America. GCDA is the world’s most inclusive cancer genomics dataset, transforming how we develop diagnostics, conduct research, and deliver cancer care so that every patient, everywhere, is truly seen and understood.
Commenting on the new lab and the unveiling of GCDA, Hitesh Goswami, CEO and Co-Founder, 4baseCare, said, “Our new genomics lab and the unveiling of the GCDA are driven by a single goal of creating better access to precision oncology. One of the key challenges in cancer care today is the lack of genomic data from Indian and Asian populations. This data gap has a significant impact on the effectiveness of cancer diagnostics and treatment strategies for under-represented communities.”
“At 4baseCare, we have firsthand seen the kind of real-world impact our genetic tests have had on cancer patients because of the right genomic data sets. Through our lab, we are creating an infrastructure to build population-specific genomic data at scale. And with GCDA, our aim is to close the diversity gap in cancer research that can change how cancer diagnosis and treatment is approached worldwide”, Hitesh added.
About 4baseCare
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare has been a pioneer in launching unique solutions in cancer care to support oncologists match patients with the right targeted therapy based on biomarker identification. 4baseCare’s best-in-class genomic-based tests include #IndiaKaGenePanel, Indiegene which is the world's first Indian population specific cancer gene panel for biomarker testing.
4baseCare is an Illumina accelerator company, backed by Infosys Innovation fund. 4baseCare also secured 6 million in series A funding round from Yali Capital, is the first Asia/Pacific company to be selected for Illumina’s accelerator program in 2019. 4baseCare has also been awarded a 5 Million INR Biotechnology Ignition Grant (BIG), a flagship scheme of Biotechnology Industry Research Assistance Council (Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Undertaking the Department of Biotechnology, Government of India. Very recently,
4baseCare has expanded its global footprint by launching operations in Dubai by establishing a state-of-the-art genomics laboratory at Dubai Science Park, in collaboration with Innovate Life Sciences. The facility has recently earned CAP Accreditation. Strengthening its international presence, the company inaugurated a new lab in the Philippines in May 2025, in partnership with LINCs Philippines.
For more details, visit, https://4basecare.com/
IndianWeb2.com is an independent digital media platform for business, entrepreneurship, science, technology, startups, gadgets and climate change news & reviews.
